1 ANNEX, Regulation (EU) 2024/2020

In forcesince 26 Jul 2024

Annex III to Implementing Regulation (EU) 2020/2235 is amended as follows:

(1)

in Chapter 29 (model ‘EU-FISH’), Part II is amended as follows:

(a)

the following Part II.1a is inserted:

‘(3) (4) [II.1a. Attestation as regards Commission Delegated Regulation (EU) 2023/905

I, the undersigned, declare that, I am aware of the relevant requirements of Regulation (EU) 2019/6 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2023/905 and hereby certify that the fishery products of aquaculture origin described in Part I were produced in accordance with these requirements, and in particular, that the aquaculture animals from which the products have been derived have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255 as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in accordance with Article 5(2) of Delegated Regulation (EU) 2023/905.]’;

(b)

in the notes to Part II, the following note is added:

‘(4) Applicable to consignments entering the Union as from 3 September 2026.’;

(2)

in Chapter 30 (model ‘FISH/MOL-CAP’), Part II is amended as follows:

(a)

the following Part II.1.a is inserted:

‘(1) (2) [II.1a. Attestation as regards Commission Delegated Regulation (EU) 2023/905

I, the undersigned, declare that, I am aware of the relevant requirements of Regulation (EU) 2019/6 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2023/905 and hereby certify that the fishery products or the fishery products derived from live bivalve molluscs/live echinoderms/live tunicates/live marine gastropods, of aquaculture origin described in Part I, were produced in accordance with these requirements, and in particular, that the aquaculture animals from which the products have been derived have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255 as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in accordance with Article 5(2) of Delegated Regulation (EU) 2023/905.]’;

(b)

in the notes to Part II, the following note is added:

‘(2) Applicable to consignments entering the Union as from 3 September 2026.’;

(3)

in Chapter 31 (model ‘MOL-HC’), Part II is amended as follows:

(a)

the following Part II.1a is inserted:

‘(4) (12) [II.1a. Attestation as regards Commission Delegated Regulation (EU) 2023/905 [Delete when the Union is not the final destination of the live bivalve molluscs, live echinoderms, live tunicates, live marine gastropods of on-land aquaculture origin and the products of animal origin derived therefrom]

I, the undersigned, declare that, I am aware of the relevant requirements of Regulation (EU) 2019/6 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2023/905 and hereby certify that the [live bivalve molluscs] (4) [live echinoderms] (4) [live tunicates] (4) [live marine gastropods] (4) of on-land aquaculture origin and the products of animal origin derived therefrom described in Part I were produced in accordance with these requirements, and in particular, that the aquaculture animals from which the products have been derived have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255 as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in accordance with Article 5(2) of Delegated Regulation (EU) 2023/905.]’;

(b)

in the notes to Part II, the following note is added:

‘(12) Applicable to consignments entering the Union as from 3 September 2026.’.